Analytical Data
-
基因名
HIRIP3
- Application
-
别名
HIRA-interacting protein 3; HIRIP3; HIRP3; HIRP3_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BW71
-
表达区间
1-556aa
-
氨基酸序列
MAREKEMQEFTRSFFRGRPDLSTLTHSIVRRRYLAHSGRSHLEPEEKQALKRLVEEELLKMQVDEAASREDKLDLTKKGKRPPTPCSDPERKRFRFNSESESGSEASSPDYFGPPAKNGVAAEVSPAKEENPRRASKAVEESSDEERQRDLPAQRGEESSEEEEKGYKGKTRKKPVVKKQAPGKASVSRKQAREESEESEAEPVQRTAKKVEGNKGTKSLKESEQESEEEILAQKKEQREEEVEEEEKEEDEEKGDWKPRTRSNGRRKSAREERSCKQKSQAKRLLGDSDSEEEQKEAASSGDDSGRDREPPVQRKSEDRTQLKGGKRLSGSSEDEEDSGKGEPTAKGSRKMARLGSTSGEESDLEREVSDSEAGGGPQGERKNRSSKKSSRKGRTRSSSSSSDGSPEAKGGKAGSGRRGEDHPAVMRLKRYIRACGAHRNYKKLLGSCCSHKERLSILRAELEALGMKGTPSLGKCRALKEQREEAAEVASLDVANIISGSGRPRRRTAWNPLGEAAPPGELYRRTLDSDEERPRPAPPDWSHMRGIISSDGESN
-
分子量
88.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HIRIP3 (HCV Interacting Protein 3) is a protein that has garnered interest due to its involvement in the life cycle of the Hepatitis C Virus (HCV). As HCV continues to be a significant global health concern, infecting millions and leading to chronic liver diseases, understanding the molecular interactions between the virus and host proteins is crucial for developing effective therapies. HIRIP3 has been identified as a key player in facilitating HCV replication and assembly, making it a potential target for antiviral drug discovery. Research has shown that HIRIP3 interacts with various viral proteins, influencing the efficiency of the HCV life cycle. Studies on recombinant HIRIP3 proteins have aimed to elucidate its structure, functional roles, and interaction networks. This knowledge not only aids in the understanding of HCV pathogenesis but also contributes to the design of innovative therapeutic strategies aimed at disrupting these viral-host interactions. Consequently, the exploration of recombinant HIRIP3 has potential implications for clinical applications, as targeting this protein may enhance therapeutic efficacy against HCV and reduce the burden of related hepatic diseases.
